[1]
Malhotra, PhD, B.K., Schoenhard, PhD, G.L., de Kater, PhD, A.W. and Friedmann, PhD, MD, N. 2015. The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy®, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment. Journal of Opioid Management. 11, 2 (Mar. 2015), 157–169. DOI:https://doi.org/10.5055/jom.2015.0265.